152 related articles for article (PubMed ID: 11319229)
61. A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis.
Jones AJ; Meunier AM
Thromb Haemost; 1990 Nov; 64(3):455-63. PubMed ID: 2128976
[TBL] [Abstract][Full Text] [Related]
62. Transport phenomena and clot dissolving therapy: an experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis.
Wu JH; Siddiqui K; Diamond SL
Thromb Haemost; 1994 Jul; 72(1):105-12. PubMed ID: 7974357
[TBL] [Abstract][Full Text] [Related]
63. Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.
Aoki N; Moroi M; Tachiya K
Thromb Haemost; 1978 Feb; 39(1):22-31. PubMed ID: 77050
[TBL] [Abstract][Full Text] [Related]
64. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
Suenson E; Thorsen S
Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
[TBL] [Abstract][Full Text] [Related]
65. Feedback regulation of endothelial cell surface plasmin generation by PKC-dependent phosphorylation of annexin A2.
He KL; Sui G; Xiong H; Broekman MJ; Huang B; Marcus AJ; Hajjar KA
J Biol Chem; 2011 Apr; 286(17):15428-39. PubMed ID: 21115493
[TBL] [Abstract][Full Text] [Related]
66. Functional characterization of a slow and tight-binding inhibitor of plasmin isolated from Russell's viper venom.
Cheng AC; Tsai IH
Biochim Biophys Acta; 2014 Jan; 1840(1):153-9. PubMed ID: 23999090
[TBL] [Abstract][Full Text] [Related]
67. Impaired clot lysis by rt-PA catalyzed mini-plasminogen activation.
Duboscq C; Genoud V; Parborell MF; Kordich LC
Thromb Res; 1997 Jun; 86(6):505-13. PubMed ID: 9219330
[TBL] [Abstract][Full Text] [Related]
68. Role of neutrophil membrane proteases in fibrin degradation.
Adams SA; Kelly SL; Kirsch RE; Robson SC; Shephard EG
Blood Coagul Fibrinolysis; 1995 Dec; 6(8):693-702. PubMed ID: 8825218
[TBL] [Abstract][Full Text] [Related]
69. Fibrin structures during tissue-type plasminogen activator-mediated fibrinolysis studied by laser light scattering: relation to fibrin enhancement of plasminogen activation.
Bauer R; Hansen SL; Jones G; Suenson E; Thorsen S; Ogendal L
Eur Biophys J; 1994; 23(4):239-52. PubMed ID: 7805626
[TBL] [Abstract][Full Text] [Related]
70. Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species.
Gurewich V; Pannell R; Louie S; Kelley P; Suddith RL; Greenlee R
J Clin Invest; 1984 Jun; 73(6):1731-9. PubMed ID: 6725557
[TBL] [Abstract][Full Text] [Related]
71. Modulation of annexin II by homocysteine: implications for atherothrombosis.
Hajjar KA; Jacovina AT
J Investig Med; 1998 Oct; 46(8):364-9. PubMed ID: 9805420
[TBL] [Abstract][Full Text] [Related]
72. Structural characterization of a dimeric complex between the short cytoplasmic domain of CEACAM1 and the pseudo tetramer of S100A10-Annexin A2 using NMR and molecular dynamics.
Hu W; Bhattacharya S; Hong T; Wong P; Li L; Vaidehi N; Kalkum M; Shively JE
Biochim Biophys Acta Biomembr; 2021 Jan; 1863(1):183451. PubMed ID: 32835655
[TBL] [Abstract][Full Text] [Related]
73. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
Doolittle RF; Pandi L
Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
[TBL] [Abstract][Full Text] [Related]
74. Characterization of human recombinant annexin II tetramer purified from bacteria: role of N-terminal acetylation.
Kang HM; Kassam G; Jarvis SE; Fitzpatrick SL; Waisman DM
Biochemistry; 1997 Feb; 36(8):2041-50. PubMed ID: 9047302
[TBL] [Abstract][Full Text] [Related]
75. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin.
Angles-Cano E; Rouy D; Lijnen HR
Biochim Biophys Acta; 1992 Dec; 1156(1):34-42. PubMed ID: 1472536
[TBL] [Abstract][Full Text] [Related]
76. Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease.
Seth D; Hogg PJ; Gorrell MD; McCaughan GW; Haber PS
J Hepatol; 2008 Apr; 48(4):614-27. PubMed ID: 18289715
[TBL] [Abstract][Full Text] [Related]
77. Modulation of annexin II tetramer by tyrosine phosphorylation.
Hubaishy I; Jones PG; Bjorge J; Bellagamba C; Fitzpatrick S; Fujita DJ; Waisman DM
Biochemistry; 1995 Nov; 34(44):14527-34. PubMed ID: 7578058
[TBL] [Abstract][Full Text] [Related]
78. Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding.
Rahman MN; Petrounevitch V; Jia Z; Koschinsky ML
Protein Eng; 2001 Jun; 14(6):427-38. PubMed ID: 11477223
[TBL] [Abstract][Full Text] [Related]
79. A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor.
Wang W; Boffa MB; Bajzar L; Walker JB; Nesheim ME
J Biol Chem; 1998 Oct; 273(42):27176-81. PubMed ID: 9765237
[TBL] [Abstract][Full Text] [Related]
80. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots.
Carr ME; Alving BM
Blood Coagul Fibrinolysis; 1995 Sep; 6(6):567-73. PubMed ID: 7578900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
